Antiphospholipid Antibodies Occurrence in Acute SARS-CoV-2 Infection without Overt Thrombosis
We sought to determine the prevalence of antiphospholipid antibodies (aPLs) and their correlation with COVID-19 severity (in terms of clinical and laboratory parameters) in patients without thrombotic events during the early phase of infection. This was a cross-sectional study with the inclusion of...
Main Authors: | Alina Dima, Daniela Nicoleta Popescu, Ruxandra Moroti, Elisabeta Stoica, Georgiana State, Florentina Negoi, Ioana Adriana Berza, Magda Parvu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/5/1241 |
Similar Items
-
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by: Lucas Jacobs, et al.
Published: (2024-03-01) -
Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
by: Riccardo Tomasello, et al.
Published: (2021-09-01) -
Heart Valve Involvement in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Study of a Single Centre
by: Isaac Pons, et al.
Published: (2023-04-01) -
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series
by: Shawn A. Mahmud, et al.
Published: (2022-08-01) -
Anti-Phosphatidylserine, Anti-Prothrombin, and Anti-Annexin V Autoantibodies in Antiphospholipid Syndrome: A Real-Life Study
by: Daniele Roselli, et al.
Published: (2023-07-01)